Article
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.
Gastroenterology - 1 Nov 2015
Foster Graham R, Pianko Stephen, Brown Ashley, Forton Daniel, Nahass Ronald G, George Jacob, Barnes Eleanor, Brainard Diana M, Massetto Benedetta, Lin Ming, Han Bin, McHutchison John G, Subramanian G Mani, Cooper Curtis, Agarwal Kosh
Abstract excerpt
BACKGROUND & AIMS: We conducted an open-label, randomized, phase 3 trial to determine the efficacy and safety of sofosbuvir and ribavirin, with and without peginterferon-alfa, in treatment-experienced patients with cirrhosis and hepatitis C virus (HCV) genotype 2 infection and treatment-naïve or treatment-experienced patients with HCV genotype 3 infection. METHODS: The study was conducted at 80 sites in Europe,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.